Pharmaceutical Technology Europe, Jun 1, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Jun 1, 2012
Packaging Forum
New Technologies Displayed at INTERPHEX
By Hallie Forcinio
Our Packaging Forum editor reports on the infamous US trade show, INTERPHEX. Highlights included the latest in pharmaceutical packaging equipment, containers and labels, as well as new capabilities among contract service providers.
Peer-Reviewed Research
Freeze-Drying Process Optimisation for a Small Molecule
By Henning Gieseler, PhD , Susanne Hibler
For true freeze-drying cycle optimisation, information on the maximum allowable product temperature during primary drying is required.
Interview
Is Pharma Getting the Best out of Social Media?
By Bhaskar Sambasivan
With social media receiving increased focus as the pharma industry strives to make the most of new communication technologies, we speak with Cognizant's Bhaskar Sambasivan to find out where pharma is when it comes to social media implementation and what more should be being done.
Ingredients
Peptides Gain Traction in Drug Development
By Patricia Van Arnum
Although representing a small part of overall drug development, peptides and related technologies to improve their production are making inroads.
Analytical
Preclinical Dose-Formulation Stability
By Amy Smith , Melissa Whitsel
A number of factors need to be considered when evaluating preclinical dose-formulation stability. The authors discuss formulation, storage and dosing conditions.
Ask the Expert
Bolstering UK Pharma with a Patent Box
By Nick Beckett
Nick Beckett from the UK law firm CMS Cameron McKenna explains how the UK government's proposed Patent Box legislation may impact the pharmaceutical sector.
Industry Insider
European regulators Struggle with Globalisation of Clinical Trials
By Nathan Jessop
The globalisation of clinical trials is putting pressure on the European Medicines Agency.
Outsourcing Review
Biomanufacturing Innovation
By Eric Langer
The industry wants more innovation, but can suppliers meet customers' needs?
News
News
By Stephanie Sutton
Pharma Aid for Developing World
Editor's Comment
Welcome!
By Jo Watts
It is with real pleasure that I join the Pharmaceutical Technology Europe (PTE) team.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here